GlassScriptPhysician profile
Barrett Blake Bradley
NPI 1821088170
$3,991.79
in general payments reported to CMS, 2019-2025
40 companies · $595 in 2025
The $595 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $744 · 2020: $175 · 2021: $526 · 2022: $877 · 2023: $516 · 2024: $558 · 2025: $595.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,670.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,669.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $507.53 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $355.58 | 2019-2025 | |
| Pfizer INC. | $315.87 | 2019-2024 | |
| Shield Therapeutics INC | $270.81 | 2023-2025 | Accrufer |
| Astellas Pharma US INC | $231.24 | 2019-2025 | Veozah, Myrbetriq |
| Novo Nordisk INC | $179.42 | 2020-2023 | |
| Aspira Women'S Health INC | $170.04 | 2020-2023 | Ova1 |
| Sage Therapeutics, LLC | $152.60 | 2024-2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $141.77 | 2023-2025 | Myfembree |
| Exeltis, USA INC. | $122.66 | 2021-2025 | Slynd |
| Axonics, INC. | $116.53 | 2022 | |
| Gynesonics, INC. | $115.34 | 2023-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Mylan Pharmaceuticals INC. | $103.50 | 2021-2022 | |
| Agile Therapeutics, INC. | $93.36 | 2022-2024 | Twirla |
| Coopersurgical, INC. | $86.57 | 2019-2024 | Paragard T 380a |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics Corporation | $82.46 | 2019 | |
| Myovant Sciences INC. | $79.74 | 2022 | |
| Intuitive Surgical, INC. | $75.72 | 2021 | |
| Mayne Pharma Commercial LLC | $74.20 | 2022-2025 | |
| Medtronic, INC. | $73.90 | 2022 | |
| Avion Pharmaceuticals | $73.48 | 2019-2023 | Balcoltra |
| Organon LLC | $73.25 | 2022-2025 | Nexplanon |
| Indivior INC. | $66.05 | 2019 | |
| Hologic Sales and Service, LLC | $45.42 | 2022-2025 | Myosure Tissue Removal Device, Novasure |
| Amag Pharmaceuticals, INC. | $42.46 | 2019-2020 | |
| Innovation Technologies INC | $41.11 | 2024 | Irrisept |
| Channel Medsystems, INC. | $38.15 | 2024 | |
| Meditrina | $37.62 | 2023-2025 | |
| Evofem Biosciences, INC. | $33.27 | 2020-2021 | |
| Therapeuticsmd, INC. | $31.66 | 2019-2020 | |
| Vivus LLC | $19.98 | 2019 | |
| Lupin INC. | $18.48 | 2021 | |
| Millicent US INC | $16.78 | 2025 | Femlyv |
| Supernus Pharmaceuticals, INC. | $16.64 | 2025 | Qelbree |
| Kci USA, INC. | $16.62 | 2023 | Prevena |
| Lilly USA, LLC | $16.08 | 2025 | Zepbound |
| Exact Sciences Corporation | $15.93 | 2025 | The Cologuard Plus Collection Kit |
| Daiichi Sankyo INC. | $13.83 | 2019 | |
| Amgen INC. | $13.49 | 2019 | |
| Convatec INC. | $12.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barrett Bradley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.